SUBSEQUENT EVENTS (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | 26 Months Ended | ||
|---|---|---|---|---|---|
Mar. 12, 2021 |
Feb. 23, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Mar. 07, 2020 |
|
| Dividend payment date | Mar. 31, 2021 | ||||
| Semi-annual cash dividend record date | Mar. 16, 2021 | ||||
| Semi-annual cash dividend per common share | $ 0.05 | $ 0.10 | $ 0.10 | ||
| ILiad Biotechnologies LLC [Member] | |||||
| Maximum convertible debt offering | $ 23,500,000 | ||||
| Interest rate | 6.00% | ||||
| Notes conversion, description | The Notes are required to be converted into a Qualified Financing (minimum financing of $15 million) at the lesser of (i) 80% of the price paid per unit in such offering or (ii) a price based on an enterprise value of $176,000,000. In addition, the Notes shall convert in the event of a merger at the lower of an enterprise value of $176,000,000 or the stated valuation of ILiAD in the merger transaction. In the event of a change-in-control, noteholders will also have the option to have the Notes repaid except in a Qualified Offering or a stock-for-stock merger. | ||||
| Additional investment | $ 1,000,000 | ||||
| Subsequent Event [Member] | |||||
| Semi-annual cash dividend per common share | $ 0.05 | ||||
| March 15, 2021 [Member] | |||||
| Number of restricted stock units issued to each non-management director | 3,750 | ||||
| June 15, 2021 [Member] | |||||
| Number of restricted stock units issued to each non-management director | 3,750 | ||||
| September 15, 2021 [Member] | |||||
| Number of restricted stock units issued to each non-management director | 3,750 | ||||
| December 15, 2021 [Member] | |||||
| Number of restricted stock units issued to each non-management director | 3,750 | ||||
| License Agreement [Member] | |||||
| Amount of royalties agreed to be paid by Cisco | $ 18,691,890 | ||||